BRMS1 downregulation is a poor prognostic biomarker in anaplastic thyroid carcinoma patients

Wu Y, Wang H, Zhi J, Hu L, Hou X, Ruan X, Zheng X, Liu H, Gao M

OncoTargets and Therapy 2019, 12:6937-6945

Published Date: 28 August 2019